Judge Allows Drug Battle Over TriCor To Proceed
In the latest in a long-running battle between pharmaceutical companies over generic versions of the cholesterol drug TriCor, a judge has ruled that a pending antitrust case against Abbott Laboratories can...To view the full article, register now.
Already a subscriber? Click here to view full article